SUBSCRIBE

Breaking News on Supplements & Nutrition - EuropeUS edition

Products > Clinical Study

Lynside® Pro GI+, an efficient and fast-acting probiotic solution

Published: 26-May-2014 | Format: PDF file | Document type: Clinical Study
Lesaffre

Provide to 10-20% of the population who’s affected by IBS and intestinal pain a safe solution.
Discover our 3 studies that have demonstrated the efficiency of our fast-acting probiotic.

Lesaffre is a main actor in the field of yeasts in the world. Based on its 160 years of experience in biotechnology, we identified and patented a specific yeast strain which is particularly efficient to target intestinal pain and discomfort : Lynside® Pro GI+.

Supplier's Info Centre

Logo Lesaffre